Wollongong Hospital is the major tertiary referral hospital located in the Wollongong Metropolitan area, New South Wales, Australia. It provides services to the entire Illawarra and Shoalhaven Region, encompassing population of approximately 350,000.

During the past decade, Wollongong Hospital - Haematology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Wollongong Hospital - Haematology" are "Multiple Myeloma" (1 trials) and "Myelodysplastic Syndromes" (1 trials). Many other conditions were trialed in "Wollongong Hospital - Haematology" in a lesser frequency.

Most popular intervention types in "Wollongong Hospital - Haematology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "CC-5013" (1 trials) and "pomalidomide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wollongong Hospital - Haematology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Wollongong Hospital - Haematology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Wollongong Hospital - Haematology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Wollongong Hospital - Haematology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".